Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
The European Respiratory Journal|May 19, 2018
What's in a name? That which we call IPF, by any other name would act the sameAthol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|June 28, 2018
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosisKevin R Flaherty, Martin Kolb, Carlo Vancheri, et al.
Journal of Thoracic Imaging|November 18, 2006
Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolutionAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Pulmonary Therapy|February 7, 2020
Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access ProgramLisa Lancaster, Lake Morrison, Alexander Auais, et al.
The Journal of Pathology|November 26, 2021
B7H3 expression and significance in idiopathic pulmonary fibrosisChuling Fang, Andrew E Rinke, Jing Wang, et al.
The New England Journal of Medicine|May 21, 2010
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis, David A Zisman, Marvin Schwarz, et al.
Respiratory Medicine|August 12, 2008
Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deathsRobert C Hyzy, William D Travis, Elizabeth Hanna, et al.
Chest|December 12, 2002
Informal caregiving for chronic lung disease among older AmericansKenneth M Langa, A Mark Fendrick, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2018
Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus StatementMargaret L Salisbury, Jeffrey L Myers, Elizabeth A Belloli, et al.
Frontiers of Medicine|January 13, 2015
Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosisBethany B Moore, Chris Fry, Yueren Zhou, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
The European Respiratory Journal|May 19, 2018
What's in a name? That which we call IPF, by any other name would act the sameAthol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|June 28, 2018
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosisKevin R Flaherty, Martin Kolb, Carlo Vancheri, et al.
Journal of Thoracic Imaging|November 18, 2006
Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolutionAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Pulmonary Therapy|February 7, 2020
Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access ProgramLisa Lancaster, Lake Morrison, Alexander Auais, et al.
The Journal of Pathology|November 26, 2021
B7H3 expression and significance in idiopathic pulmonary fibrosisChuling Fang, Andrew E Rinke, Jing Wang, et al.
The New England Journal of Medicine|May 21, 2010
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis, David A Zisman, Marvin Schwarz, et al.
Respiratory Medicine|August 12, 2008
Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deathsRobert C Hyzy, William D Travis, Elizabeth Hanna, et al.
Chest|December 12, 2002
Informal caregiving for chronic lung disease among older AmericansKenneth M Langa, A Mark Fendrick, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2018
Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus StatementMargaret L Salisbury, Jeffrey L Myers, Elizabeth A Belloli, et al.
Frontiers of Medicine|January 13, 2015
Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosisBethany B Moore, Chris Fry, Yueren Zhou, et al.
Pageof 21